Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Final Results of CheckMate 722.
Tony S K MokKazuhiko NakagawaKeunchil ParkYuichiro OheNicolas GirardHye Ryun KimYi-Long WuJustin F GainorSe-Hoon LeeChao-Hua ChiuSang-We KimCheng-Ta YangChien Liang WuLin WuMeng-Chih LinJens SamolKazuya IchikadoMengzhao WangXiaoqing ZhangJudi SylvesterSunney LiAnn ForslundJames Chih-Hsin YangPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
mutated metastatic NSCLC previously treated with EGFR TKIs. No new safety signals were identified.